5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% (December 2025)

A monthly screening identifies five large-cap, relatively conservative dividend-growing companies trading at discounts to their historical norms, selected from roughly 7,500 U.S.-listed securities using proprietary filters; the primary group yields about 3.6%, while two supplemental quintets target moderate-to-high yields up to ~8%. The author, Financially Free Investor, frames the selections within a dividend-growth, three-basket approach aimed at lower drawdowns and multi-percent current income targets, and discloses extensive long positions across many large-cap names.

Analysis

Market structure: The article signals renewed demand for large-cap, dividend-paying defensive names (primary basket ~3.6% yield, secondary up to 8%), benefiting staples, healthcare, integrated energy and high-quality REITs (e.g., JNJ, ABBV, XOM, ENB, O, NNN). Losers are rate-sensitive growth and small caps as yield-seeking flows reallocate capital; expect lower implied vols and tighter credit spreads for rated dividend payers over 1–6 months. Cross-asset: a continued flight to yield compresses equity risk premia vs. Treasuries — if 10y stays <4.0% equity dividend plays outperform; if 10y >4.5% expect further rotation back to cash/bonds.

Risk assessment: Tail risks include a Fed surprise hiking into recession (10y >4.5% or two consecutive CPI prints >0.5% m/m) that forces dividend cuts in cyclical payers and energy price collapses that hit MLPs/ENB. Short-term (days–weeks) moves driven by CPI and Fed minutes; medium (3–6 months) risks are patent cliffs/regulatory actions for pharma (PFE, ABBV, NVS) and FX swings for multinationals (NVO, NVS). Hidden dependencies: buyback pace and corporate credit availability; a slowdown in buybacks would materially reduce total shareholder return for many names.

Trade implications: Favor 12-month overweight to high-quality dividend growers (JNJ, ABBV, MCD, XOM) and high-dividend REITs (O, NNN) while trimming cyclical materials/energy refiners (LYB, VLO) if commodity signals weaken. Use covered-call overlays to harvest yield in low-IV names and buy protective puts on cyclical dividend payers if CDS spreads widen >50bps. Pair trades: long ABBV vs short biotech small-cap basket to exploit lower beta and steadier cash flow; exit rules tied to spread tightening of 50% or after 9–12 months.

Contrarian angles: Consensus underestimates FX and buyback fragility — many dividend yields look attractive only if buybacks persist; a modest contraction (‑25% YoY) in buybacks would reduce S&P dividend+buyback yield significantly. Past parallels (2011, 2016) show dividend chasing reverses quickly when real yields reprice; therefore positions should be sized for drawdowns (expect 10–20% swings) and monitored around Fed/CPI windows over next 3 months.

Key Decisions for Investors

• Establish a 2–3% long position in JNJ and a 2% long in ABBV within 10 business days; add an incremental 1% on any single-stock drop >5%; target 12-month total return 8–12% and collect yields ~2.5–4%.
• Rotate 5–7% of portfolio from cyclical materials/refiners (LYB, VLO, ITW) into high-quality REITs/MLPs (ENB, O, NNN) over the next 30 days to lower portfolio beta by ~0.25–0.35 and increase income by ~0.6–1.0%.
• Implement income overlay: sell 30–60 day covered calls 5–10% OTM on AAPL/MSFT positions to capture annualized premium ~6–10%; simultaneously buy 3–6 month protective puts on ABBV or XOM if implied vol for those names rises >40% of the 90-day median.
• Initiate a relative-value pair: long UNH (1.5% position) vs short PRU (1.5% position) for 6–12 months, betting on healthcare margin resilience vs financial cyclicality; cut pair if spread moves against position by 50% or after 12 months.